NATALIA POLESCHUK: Open Payments
NPI 1588930226 · BRENTWOOD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$123 in 6 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $41 · 2025 $123
Food & beverage: $123
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $54 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $39 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| SCILEX PHARMACEUTICALS INC. | 1 | $14 |
Products named: SHINGRIX, XIFAXAN, ZORYVE, ELYXYB - CELECOXIB.
Industry payments across CA — which companies pay providers there.
